TY - JOUR AU - Mansky, L. M. AU - Temin, H. M. PY - 1995 DA - 1995// TI - Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase JO - Journal of Virology VL - 69 ID - Mansky1995 ER - TY - JOUR AU - Levy, D. N. AU - Aldrovandi, G. M. AU - Kutsch, O. AU - Shaw, G. M. PY - 2004 DA - 2004// TI - Dynamics of HIV-1 recombination in its natural target cells JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0306764101 DO - 10.1073/pnas.0306764101 ID - Levy2004 ER - TY - JOUR AU - Perelson, A. S. AU - Neumann, A. U. AU - Markowitz, M. AU - Leonard, J. M. AU - Ho, D. D. PY - 1996 DA - 1996// TI - HIV-1 dynamics in vivo: virion clearance rate, infected cell lifetime, and viral generation time JO - Science VL - 271 UR - https://doi.org/10.1126/science.271.5255.1582 DO - 10.1126/science.271.5255.1582 ID - Perelson1996 ER - TY - JOUR AU - Bourinbaiar, A. S. PY - 1994 DA - 1994// TI - The ratio of defective HIV-1 particles to replication-competent infectious virions JO - Acta Virol VL - 38 ID - Bourinbaiar1994 ER - TY - JOUR AU - Li, Y. AU - Hui, H. AU - Burgess, C. J. AU - Price, R. W. AU - Sharp, P. M. AU - Hahn, B. H. AU - Shaw, G. M. PY - 1992 DA - 1992// TI - Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation JO - Journal of Virology VL - 66 ID - Li1992 ER - TY - JOUR AU - Sanchez, G. AU - Xu, X. AU - Chermann, J. C. AU - Hirsch, I. PY - 1997 DA - 1997// TI - Accumulation of defective viral genomes in peripheral blood mononuclear cells fo HIV infected individuals JO - Journal of Virology VL - 71 ID - Sanchez1997 ER - TY - JOUR AU - Eigen, M. PY - 1971 DA - 1971// TI - Selforganization of matter and the evolution of biological macromolecules JO - Naturwissenschaften VL - 58 UR - https://doi.org/10.1007/BF00623322 DO - 10.1007/BF00623322 ID - Eigen1971 ER - TY - JOUR AU - Eigen, M. PY - 2002 DA - 2002// TI - Error catastrophe and antiviral strategy JO - Proc Natl Acad Sci U S A VL - 99 UR - https://doi.org/10.1073/pnas.212514799 DO - 10.1073/pnas.212514799 ID - Eigen2002 ER - TY - JOUR AU - Loeb, L. A. AU - Essigmann, J. M. AU - Kazazi, F. AU - Zhang, J. AU - Rose, K. D. AU - Mullins, J. I. PY - 1999 DA - 1999// TI - Lethal mutagenesis of HIV with mutagenic nucleoside analogs JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.4.1492 DO - 10.1073/pnas.96.4.1492 ID - Loeb1999 ER - TY - JOUR AU - Smith, R. A. AU - Loeb, L. A. AU - Preston, B. D. PY - 2005 DA - 2005// TI - Lethal mutagenesis of HIV JO - Virus Res VL - 107 UR - https://doi.org/10.1016/j.virusres.2004.11.011 DO - 10.1016/j.virusres.2004.11.011 ID - Smith2005 ER - TY - JOUR AU - Crotty, S. AU - Maag, D. AU - Arnold, J. J. AU - Zhong, W. AU - Lau, J. Y. AU - Hong, Z. AU - Andino, R. AU - Cameron, C. E. PY - 2000 DA - 2000// TI - The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen JO - Nat Med VL - 6 UR - https://doi.org/10.1038/82191 DO - 10.1038/82191 ID - Crotty2000 ER - TY - JOUR AU - Lau, J. Y. AU - Tam, R. C. AU - Liang, T. J. AU - Hong, Z. PY - 2002 DA - 2002// TI - Mechanism of action of ribavirin in the combination treatment of chronic HCV infection JO - Hepatology VL - 35 UR - https://doi.org/10.1053/jhep.2002.32672 DO - 10.1053/jhep.2002.32672 ID - Lau2002 ER - TY - JOUR AU - Lecossier, D. AU - Bouchonnet, F. AU - Clavel, F. AU - Hance, A. J. PY - 2003 DA - 2003// TI - Hypermutation of HIV-1 DNA in the absence of the Vif protein JO - Science VL - 300 UR - https://doi.org/10.1126/science.1083338 DO - 10.1126/science.1083338 ID - Lecossier2003 ER - TY - JOUR AU - Zheng, Y. H. AU - Irwin, D. AU - Kurosu, T. AU - Tokunaga, K. AU - Sata, T. AU - Peterlin, B. M. PY - 2004 DA - 2004// TI - Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.11.6073-6076.2004 DO - 10.1128/JVI.78.11.6073-6076.2004 ID - Zheng2004 ER - TY - JOUR AU - Sheehy, A. M. AU - Gaddis, N. C. AU - Choi, J. D. AU - Malim, M. H. PY - 2002 DA - 2002// TI - Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein JO - Nature VL - 418 UR - https://doi.org/10.1038/nature00939 DO - 10.1038/nature00939 ID - Sheehy2002 ER - TY - JOUR AU - Sheehy, A. M. AU - Gaddis, N. C. AU - Malim, M. H. PY - 2003 DA - 2003// TI - The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm945 DO - 10.1038/nm945 ID - Sheehy2003 ER - TY - JOUR AU - Stopak, K. AU - de Noronha, C. AU - Yonemoto, W. AU - Greene, W. C. PY - 2003 DA - 2003// TI - HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability JO - Mol Cell VL - 12 UR - https://doi.org/10.1016/S1097-2765(03)00353-8 DO - 10.1016/S1097-2765(03)00353-8 ID - Stopak2003 ER - TY - JOUR AU - Mezei, M. AU - Minarovits, J. PY - 2006 DA - 2006// TI - Reversal of HIV drug resistance and novel strategies to curb HIV infection: the viral infectivity factor Vif as a target and tool of therapy JO - Curr Drug Targets VL - 7 UR - https://doi.org/10.2174/138945006777709610 DO - 10.2174/138945006777709610 ID - Mezei2006 ER - TY - JOUR AU - Carr, J. M. AU - Davis, A. J. AU - Feng, F. AU - Burrell, C. J. AU - Li, P. PY - 2006 DA - 2006// TI - Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more? JO - Curr Drug Targets VL - 7 UR - https://doi.org/10.2174/138945006779025356 DO - 10.2174/138945006779025356 ID - Carr2006 ER - TY - JOUR AU - Stopak, K. AU - Greene, W. C. PY - 2005 DA - 2005// TI - Protecting APOBEC3G: a potential new target for HIV drug discovery JO - Curr Opin Investig Drugs VL - 6 ID - Stopak2005 ER - TY - JOUR AU - Fessel, J. PY - 2005 DA - 2005// TI - A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem JO - Med Hypotheses VL - 64 UR - https://doi.org/10.1016/j.mehy.2004.07.015 DO - 10.1016/j.mehy.2004.07.015 ID - Fessel2005 ER - TY - JOUR AU - Hirsch, M. S. PY - 2002 DA - 2002// TI - HIV drug resistance--a chink in the armor JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMe020072 DO - 10.1056/NEJMe020072 ID - Hirsch2002 ER - TY - JOUR AU - Suspene, R. AU - Sommer, P. AU - Henry, M. AU - Ferris, S. AU - Guetard, D. AU - Pochet, S. AU - Chester, A. AU - Navaratnam, N. AU - Wain-Hobson, S. AU - Vartanian, J. P. PY - 2004 DA - 2004// TI - APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase JO - Nucleic Acids Res VL - 32 UR - https://doi.org/10.1093/nar/gkh554 DO - 10.1093/nar/gkh554 ID - Suspene2004 ER - TY - JOUR AU - Suspene, R. AU - Rusniok, C. AU - Vartanian, J. P. AU - Wain-Hobson, S. PY - 2006 DA - 2006// TI - Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication JO - Nucleic Acids Res VL - 34 UR - https://doi.org/10.1093/nar/gkl555 DO - 10.1093/nar/gkl555 ID - Suspene2006 ER - TY - JOUR AU - Yu, Q. AU - Konig, R. AU - Pillai, S. AU - Chiles, K. AU - Kearney, M. AU - Palmer, S. AU - Richman, D. AU - Coffin, J. M. AU - Landau, N. R. PY - 2004 DA - 2004// TI - Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome JO - Nat Struct Mol Biol VL - 11 UR - https://doi.org/10.1038/nsmb758 DO - 10.1038/nsmb758 ID - Yu2004 ER - TY - JOUR AU - Xu, H. AU - Chertova, E. AU - Chen, J. AU - Ott, D. E. AU - Roser, J. D. AU - Hu, W. S. AU - Pathak, V. K. PY - 2007 DA - 2007// TI - Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions JO - Virology VL - 360 UR - https://doi.org/10.1016/j.virol.2006.10.036 DO - 10.1016/j.virol.2006.10.036 ID - Xu2007 ER - TY - JOUR AU - Khan, M. A. AU - Goila-Gaur, R. AU - Opi, S. AU - Miyagi, E. AU - Takeuchi, H. AU - Kao, S. AU - Strebel, K. PY - 2007 DA - 2007// TI - Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions JO - Retrovirology VL - 4 UR - https://doi.org/10.1186/1742-4690-4-48 DO - 10.1186/1742-4690-4-48 ID - Khan2007 ER - TY - JOUR AU - Chen, K. M. AU - Martemyanova, N. AU - Lu, Y. AU - Shindo, K. AU - Matsuo, H. AU - Harris, R. S. PY - 2007 DA - 2007// TI - Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G JO - FEBS Lett VL - 581 UR - https://doi.org/10.1016/j.febslet.2007.08.076 DO - 10.1016/j.febslet.2007.08.076 ID - Chen2007 ER - TY - JOUR AU - Opi, S. AU - Takeuchi, H. AU - Kao, S. AU - Khan, M. A. AU - Miyagi, E. AU - Goila-Gaur, R. AU - Iwatani, Y. AU - Levin, J. G. AU - Strebel, K. PY - 2006 DA - 2006// TI - Monomeric APOBEC3G is catalytically active and has antiviral activity JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.80.10.4673-4682.2006 DO - 10.1128/JVI.80.10.4673-4682.2006 ID - Opi2006 ER - TY - JOUR AU - Mansky, L. M. AU - Pearl, D. K. AU - Gajary, L. C. PY - 2002 DA - 2002// TI - Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies JO - J Virol VL - 76 UR - https://doi.org/10.1128/JVI.76.18.9253-9259.2002 DO - 10.1128/JVI.76.18.9253-9259.2002 ID - Mansky2002 ER - TY - JOUR AU - Summers, J. AU - Litwin, S. PY - 2006 DA - 2006// TI - Examining the theory of error catastrophe JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.80.1.20-26.2006 DO - 10.1128/JVI.80.1.20-26.2006 ID - Summers2006 ER - TY - JOUR AU - Bull, J. J. AU - Sanjuan, R. AU - Wilke, C. O. PY - 2007 DA - 2007// TI - Theory of lethal mutagenesis for viruses JO - J Virol VL - 81 UR - https://doi.org/10.1128/JVI.01624-06 DO - 10.1128/JVI.01624-06 ID - Bull2007 ER - TY - JOUR AU - Berkhout, B. AU - de Ronde, A. PY - 2004 DA - 2004// TI - APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations JO - Aids VL - 18 UR - https://doi.org/10.1097/00002030-200409030-00022 DO - 10.1097/00002030-200409030-00022 ID - Berkhout2004 ER - TY - JOUR AU - Liddament, M. T. AU - Brown, W. L. AU - Schumacher, A. J. AU - Harris, R. S. PY - 2004 DA - 2004// TI - APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo JO - Curr Biol VL - 14 UR - https://doi.org/10.1016/j.cub.2004.06.050 DO - 10.1016/j.cub.2004.06.050 ID - Liddament2004 ER - TY - JOUR AU - Johnson, V. A. AU - Brun-Vezinet, F. AU - Clotet, B. AU - Kuritzkes, D. R. AU - Pillay, D. AU - Schapiro, J. M. AU - Richman, D. D. PY - 2006 DA - 2006// TI - Update of the drug resistance mutations in HIV-1: Fall 2006 JO - Top HIV Med VL - 14 ID - Johnson2006 ER - TY - JOUR AU - Carvajal-Rodriguez, A. AU - Crandall, K. A. AU - Posada, D. PY - 2007 DA - 2007// TI - Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy JO - Infect Genet Evol VL - 7 UR - https://doi.org/10.1016/j.meegid.2007.02.001 DO - 10.1016/j.meegid.2007.02.001 ID - Carvajal-Rodriguez2007 ER - TY - JOUR AU - Moutouh, L. AU - Corbeil, J. AU - Richman, D. D. PY - 1996 DA - 1996// TI - Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.12.6106 DO - 10.1073/pnas.93.12.6106 ID - Moutouh1996 ER - TY - JOUR AU - Kellam, P. AU - Larder, B. A. PY - 1995 DA - 1995// TI - Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance JO - Journal of Virology VL - 69 ID - Kellam1995 ER - TY - JOUR AU - Yuste, E. AU - Sanchez-Palomino, S. AU - Casado, C. AU - Domingo, E. AU - Lopez-Galindez, C. PY - 1999 DA - 1999// TI - Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events JO - J Virol VL - 73 ID - Yuste1999 ER - TY - STD TI - Los Alamos National Lab HIV Sequence Database. [http://www.hiv.lanl.gov] UR - http://www.hiv.lanl.gov ID - ref40 ER - TY - JOUR AU - Pace, C. AU - Keller, J. AU - Nolan, D. AU - James, I. AU - Gaudieri, S. AU - Moore, C. AU - Mallal, S. PY - 2006 DA - 2006// TI - Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00888-06 DO - 10.1128/JVI.00888-06 ID - Pace2006 ER - TY - JOUR AU - Simon, V. AU - Zennou, V. AU - Murray, D. AU - Huang, Y. AU - Ho, D. D. AU - Bieniasz, P. D. PY - 2005 DA - 2005// TI - Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification JO - PLoS Pathog VL - 1 UR - https://doi.org/10.1371/journal.ppat.0010006 DO - 10.1371/journal.ppat.0010006 ID - Simon2005 ER - TY - JOUR AU - Cho, S. J. AU - Drechsler, H. AU - Burke, R. C. AU - Arens, M. Q. AU - Powderly, W. AU - Davidson, N. O. PY - 2006 DA - 2006// TI - APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.80.4.2069-2072.2006 DO - 10.1128/JVI.80.4.2069-2072.2006 ID - Cho2006 ER - TY - JOUR AU - Jin, X. AU - Wu, H. AU - Smith, H. PY - 2007 DA - 2007// TI - APOBEC3G levels predict rates of progression to AIDS JO - Retrovirology VL - 4 UR - https://doi.org/10.1186/1742-4690-4-20 DO - 10.1186/1742-4690-4-20 ID - Jin2007 ER - TY - JOUR AU - An, P. AU - Bleiber, G. AU - Duggal, P. AU - Nelson, G. AU - May, M. AU - Mangeat, B. AU - Alobwede, I. AU - Trono, D. AU - Vlahov, D. AU - Donfield, S. AU - Goedert, J. J. AU - Phair, J. AU - Buchbinder, S. AU - O'Brien, S. J. AU - Telenti, A. AU - Winkler, C. A. PY - 2004 DA - 2004// TI - APOBEC3G genetic variants and their influence on the progression to AIDS JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.20.11070-11076.2004 DO - 10.1128/JVI.78.20.11070-11076.2004 ID - An2004 ER - TY - JOUR AU - Desrosiers, R. C. PY - 2004 DA - 2004// TI - Prospects for an AIDS vaccine JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm0304-221 DO - 10.1038/nm0304-221 ID - Desrosiers2004 ER - TY - JOUR AU - Chiu, Y. L. AU - Soros, V. B. AU - Kreisberg, J. F. AU - Stopak, K. AU - Yonemoto, W. AU - Greene, W. C. PY - 2005 DA - 2005// TI - Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells JO - Nature VL - 435 UR - https://doi.org/10.1038/nature03493 DO - 10.1038/nature03493 ID - Chiu2005 ER - TY - JOUR AU - Bishop, K. N. AU - Holmes, R. K. AU - Malim, M. H. PY - 2006 DA - 2006// TI - Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00839-06 DO - 10.1128/JVI.00839-06 ID - Bishop2006 ER - TY - JOUR AU - Soros, V. B. AU - Yonemoto, W. AU - Greene, W. C. PY - 2007 DA - 2007// TI - Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H JO - PLoS Pathog VL - 3 UR - https://doi.org/10.1371/journal.ppat.0030015 DO - 10.1371/journal.ppat.0030015 ID - Soros2007 ER - TY - JOUR AU - Miyagi, E. AU - Opi, S. AU - Takeuchi, H. AU - Khan, M. AU - Goila-Gaur, R. AU - Kao, S. AU - Strebel, K. PY - 2007 DA - 2007// TI - Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1 JO - J Virol VL - 81 UR - https://doi.org/10.1128/JVI.01361-07 DO - 10.1128/JVI.01361-07 ID - Miyagi2007 ER - TY - STD TI - Stanford HIV Drug Resistance Database . [http://hivdb.stanford.edu/] UR - http://hivdb.stanford.edu/ ID - ref51 ER -